An incidence of sarcopenia in patients with stable chronic obstructive pulmonary disease: a comparison of diagnostic algorithms of European Working Group on Sarcopenia in Older People, 2018 versus 2010

Сулейманова, А. К.; Сафонова, Ю. А.; Баранова, И. А.

doi:10.18093/0869-0189-2019-29-5-564-570

Cited by 2 publications

(2 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As evidenced by the Methodological scoring system ( Fig 1 ). Ten of the studies [ 7 – 9 , 11 , 13 , 16 – 20 ] were not prospective studies, and only five studies included [ 9 , 17 , 20 – 22 ] sample sizes over 300. Furthermore, only three studies used an unbiased sampling frame [ 7 , 17 , 19 ], two were multi-center clinical trials [ 7 , 21 ], one was based on database [ 17 ].…”

Section: Resultsmentioning

confidence: 99%

“…The variability may be attributed to several reasons. First, the definition of sarcopenia has not been standardized [ 11 ], with the presence of multiple organizations such as the definition of European Working Group on Sarcopenia in Older People (EWGSOP) or the Asian Working Group for Sarcopenia (AWGS). Second, inaccuracies in prevalence may arise from differences in the quality and quantity of the analyzed studies and the sampling strategies.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Chronic obstructive pulmonary disease as a risk factor for sarcopenia: A systematic review and meta-analysis

Yu,

He,

Chen

et al. 2024

PLoS ONE

View full text Add to dashboard Cite

Sarcopenia prevalence and its risk factors in chronic obstructive pulmonary disease (COPD) vary partly due to definition criteria. This systematic review aimed to identify the prevalence and risk factors of sarcopenia in COPD patients. This review was registered in PROSPERO (CRD42022310750). Nine electronic databases were searched from inception to September 1st, 2022, and studies related to sarcopenia and COPD were identified. Study quality was assessed using a validated scale matched to study designs, and a meta-analysis was performed to evaluate sarcopenia prevalence. COPD patients with sarcopenia were compared to those without sarcopenia for BMI, smoking, and mMRC. The current meta-analysis included 15 studies, with a total of 7,583 patients. The overall sarcopenia prevalence was 29% [95% CI: 22%–37%], and the OR of sarcopenia in COPD patients was 1.51 (95% CI: 1.19–1.92). The meta-analysis and systematic review showed that mMRC (OR = 2.02, P = 0.04) and age (OR = 1.15, P = 0.004) were significant risk factors for sarcopenia in COPD patients. In contrast, no significant relationship was observed between sarcopenia and smoking and BMI. Nursing researchers should pay more attention to the symptomatic management of COPD and encourage patients to participate in daily activities in the early stages of the disease.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Chronic obstructive pulmonary disease as a risk factor for sarcopenia: A systematic review and meta-analysis

Yu,

He,

Chen

et al. 2024

PLoS ONE

View full text Add to dashboard Cite

show abstract

Frailty and senile apathy in the everyday clinical practice in the conditions of COVID-19

Veselova

Белопасов

2022

Journal of Clinical Practice

View full text Add to dashboard Cite

The article covers the pathogenesis, clinical manifestations, and diagnostic criteria of frailty and senile apathy in the elderly. Special attention is paid to sarcopenia: the phenotypic classification and modern approaches to the treatment are discussed. The knowledge and understanding of the main pathogenetic links of sarcopenia, frailty and senile apathy, as well as the development of a single therapeutic line for these pathological conditions can significantly improve the life quality and expectancy of the elderly.

show abstract

An incidence of sarcopenia in patients with stable chronic obstructive pulmonary disease: a comparison of diagnostic algorithms of European Working Group on Sarcopenia in Older People, 2018 versus 2010

Cited by 2 publications

References 10 publications

Chronic obstructive pulmonary disease as a risk factor for sarcopenia: A systematic review and meta-analysis

Chronic obstructive pulmonary disease as a risk factor for sarcopenia: A systematic review and meta-analysis

Frailty and senile apathy in the everyday clinical practice in the conditions of COVID-19

Contact Info

Product

Resources

About